100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
1049718-43-5Bupropion Related Compound B (HCl Salt)
● In Stock
| Catalogue No.: | VL25016 |
|---|---|
| CAS No.: | 1049718-43-5 |
| Mol. Formula: | C13H18BrNO.HCl |
| Mol. Weight: | 320.65 g/mol |
Order Online
Additional information on CAS 1049718-43-5
Parent drug
BupropionIUPAC Name
(2-tert butylamino)-3-Bromopropiophenone hydrochloridePharmacopoeial Synonyms
N/AOther Synonyms
3-Bromopropiophenone; 1-(3-Bromophenyl)-2-(tert-butylamino)propan-1-one HydrochlorideSmile
O=C(C1=CC=CC=C1)C(NC(C)(C)C)CBr.[H]ClInChI
InChI=1S/C13H18BrNO.ClH/c1-13(2,3)15-11(9-14)12(16)10-7-5-4-6-8-10;/h4-8,11,15H,9H2,1-3H3;1HDescription
Bupropion Related Compound B (HCl salt), CAS 1049718-43-5, is the hydrochloride salt of a brominated bupropion analog with molecular formula C13H18BrNO.HCl and molecular weight 320.65 g/mol. Structurally, it represents a halogenated amphetamine-like ketone impurity associated with synthetic route-related formation or intermediate carryover rather than oxidative degradation. Its ionic character and aromatic bromine substituent influence chromatographic retention and ionization behavior. Trace-level determination typically requires LC-MS/MS, often complemented by LC-UV or high-resolution LC-MS for identity confirmation. In impurity profiling, it is evaluated as a structurally related specified impurity under regulatory specifications and ICH Q3A principles.Request a Quote
"*" indicates required fields
Other products related to Bupropion impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
